Stony Brook University

In addition to the bypass surgery, Stony Brook surgeons regularly perform the full spectrum of cardiac lifesaving procedures including Transcatheter Aortic Valve Replacement (TAVR), Mitral Valve Repair, Electrophysiology and Cardiac Catheterization. Photo from Stony Brook Medicine

The Cardiothoracic Surgery Division at Stony Brook University Heart Institute has earned a distinguished three-star rating from The Society of Thoracic Surgeons (STS) for its patient care and outcomes in isolated coronary artery bypass grafting (CABG) procedures in 2020. The three-star rating, which denotes the highest category of quality, places Stony Brook University Hospital among the elite for heart bypass surgery in the United States and Canada. The Stony Brook Heart Institute received two back-to-back three-star ratings from The Society of Thoracic Surgeons (STS) in 2017 and 2018, and now an overall three-star rating for 2020.

This elite rating is reflective of our entire organization’s commitment to quality and safety — from preoperative planning to thorough coordination among multidisciplinary team members — for the optimal outcome for the patient receiving cardiac care,” says Margaret McGovern, MD, PhD, Dean for Clinical Affairs and Vice President, Health System Clinical Programs.

“At Stony Brook, we take great pride in our comprehensive heart program that has a long legacy of bringing the highest quality standards to benefit our patients and their families,” says Carol Gomes, Chief Executive Office, Stony Brook University Hospital. “And we remain laser-focused on serving our community with the most advanced technology, our outstanding cardiovascular staff and the full spectrum of lifesaving cardiac interventions.”

“The three-star rating is a testament to our team’s deep commitment to bringing the best in cardiac care to our community,” says Henry J. Tannous, MD, Co-Director of the Heart Institute, Chief of Cardiothoracic Surgery and General T.F. Cheng Chair, Cardiothoracic Surgery, Renaissance School of Medicine at Stony Brook University. “Patients can have peace of mind knowing they’re getting care from one of the top-rated facilities in the nation.”

The STS star rating system is one of the most sophisticated and highly regarded overall measures of quality in health care, rating the benchmarked outcomes of cardiothoracic surgery programs across the United States and Canada. The star rating is calculated using a combination of quality measures for specific procedures performed by an STS Adult Cardiac Surgery Database participant. For 2020, 6.1% of participants received the three-star rating for isolated CABG surgery.

“The Society of Thoracic Surgeons congratulates STS National Database participants who have received three-star ratings,” said David M. Shahian, MD, chair of the Task Force on Quality Measurement. “Participation in the Database and public reporting demonstrates a commitment to quality improvement in health care delivery and helps provide patients and their families with meaningful information to help them make informed decisions about health care.”

The STS National Database was established in 1989 as an initiative for quality improvement and patient safety among cardiothoracic surgeons. The Database includes four components: the Adult Cardiac Surgery Database (ACSD), the Congenital Heart Surgery Database (CHSD), the General Thoracic Surgery Database (GTSD), and the mechanical circulatory support database (Intermacs). The STS ACSD houses approximately 7.4 million surgical records and gathers information from more than 3,500 participating physicians, including surgeons and anesthesiologists from more than 90% of groups that perform heart surgery in the US. STS public reporting online enables STS ACSD participants to voluntarily report to each other and the public their heart surgery scores and star ratings.

“The STS rating is based on the Division of Cardiothoracic Surgery’s experience in coronary artery bypass grafting (CABG) surgery, and we believe that the quality and expertise illustrated by the top rating is reflective of the entire Heart Institute’s dedication to excellence in patient care,” says Dr. Tannous.

About Stony Brook University Heart Institute:

Stony Brook University Heart Institute is located within Stony Brook University Hospital as part of Long Island’s premier university-based medical center. The Heart Institute offers a comprehensive, multidisciplinary program for the prevention, diagnosis and treatment of cardiovascular disease. The staff includes full-time and community-based, board-certified cardiologists and cardiothoracic surgeons, as well as specially trained anesthesiologists, nurses, physician assistants, nurse practitioners, respiratory therapists, surgical technologists, perfusionists, and other support staff. Their combined expertise provides state-of-the-art interventional and surgical capabilities in 24-hour cardiac catheterization labs and surgical suites. And while the Heart Institute clinical staff offers the latest advances in medicine, its physician-scientists are also actively enhancing knowledge of the heart and blood vessels through basic biomedical studies and clinical research. To learn more, visit www.heart.stonybrookmedicine.edu.

About STS:

The Society of Thoracic Surgeons (STS) is a not-for-profit organization that represents more than 7,500 surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society’s mission is to advance cardiothoracic surgeons’ delivery of the highest quality patient care through collaboration, education, research, and advocacy.

A scene from Willow. Photo courtesy of Banana Films
Watch in-person or virtually this year!

Stony Brook University’s Staller Center for the Arts turns into a movie lover’s mecca when new independent films screen at the Stony Brook Film Festival on evenings and weekends from Thursday, July 22 to Saturday, July 31. The popular festival, now in its 26th year, pairs memorable short films with an array of features you won’t see anywhere else, making it a favorite of moviegoers and filmmakers alike.

The live, in-person screening of the film festival, presented by Island Federal, will be followed up by a virtual festival from Aug. 5 to 30 on the IndieFlix Festivals app. 

Presented by Island Federal, the 2021 Festival lineup boasts 35 films from over 15 countries and includes never-before-seen features from around the globe. The Festival kicks off with the world premiere of The 5th Man, a documentary on Paul Limmer, a former track coach at Bellmore’s Mepham High School. During his 50-year career there, Limmer racked up hundreds of wins, though director Trey Nelson focuses on the story of all the other kids – the ones who never felt “seen” – until Paul Limmer came into their lives. 

The film will be preceded by Feeling Through, an Oscar-nominated short featuring deaf-blind actor Robert Tarango of Selden. Other must-see features include Yamina Benguigui’s Sisters, starring Isabelle Adjani and Maïwenn, a finely crafted reflection on memory and belonging to two worlds and As Far As I Know, an uncompromising film that wrestles with questions of perspective and victimhood. Milcho Manchevski’s newest masterpiece Willow is resplendent in unforgettable images and unconventional narrative. Closing out the 2021 Festival is the intense and complexly drawn sports drama Final Set.

FILM SCHEDULE

OPENING NIGHT

Thursday, July 22 at 8 p.m.

Feature: The 5th Man, United States

Short: Feeling Through, United States

 

Friday, July 23 at 7 p.m.

Feature: Risks & Side Effects, Germany

Short: David, United States

Friday, July 23 at 9:15 p.m.

Feature: Red River Road, United States

Short: The Following Year, Spain

 

Saturday, July 24 at 7 p.m.

Feature: Sisters, France

Short: Girls Are Strong Here, U.S.

Saturday, July 24 at 9:15 p.m.

Feature: Games People Play, Finland

Short: Off Duty, United States

 

Sunday, July 25 at 7 p.m.

Feature: Persona Non Grata, Denmark

Short: On the Sidewalk, at Night, U.S.

Sunday, July 25 at 9:15 p.m.

Feature: Anchorage, United States

Short: The Saverini Widow, France

 

Monday, July 26 at 7 p.m.

Feature: As Far As I Know, Hungary

Short: DA YIE, Ghana

Monday, July 26 at 9:15 p.m.

Feature: Willow, Republic of Northern Macedonia, Hungary, Belgium

Short: The Night I Left America, U.S.

 

Tuesday, July 27 at 7 p.m.

Feature: Fire in the Mountains, India

Short: The Music Video, Canada

Tuesday, July 27 at 9:15 p.m.

Feature: Everything in the End, U.S.

Short: Max is Bleeding, U.S.

 

Wednesday, July 28 at 7 p.m.

Feature: Sun Children, Iran

Short: Noisy, United States

Wednesday, July 28 at 9:15 p.m.

Feature: The Castle, Lithuania, Ireland

Short: Inverno (Timo’s Winter), Italy

 

Thursday, July 29 at 7 p.m.

Feature: Murder at Cinema North, Israel

Short: Devek, Israel

Thursday, July 29 at 9:15 p.m.

Feature: How to Stop a Recurring Dream, United Kingdom

Short: This Uncertain Moment, U.S.

 

Friday, July 30 at 7 p.m.

Feature: Lorelei, United States

Short: Swipe, United States

Friday, July 30 at 9:15 p.m.

Feature: Perfumes, France

Short: Ganef, United Kingdom

 

CLOSING NIGHT

Saturday, July 31 at 8 p.m.

Feature: Final Set, France

CLOSING NIGHT AWARDS

10:30 p.m.

Ticket information

All live screenings are held at Stony Brook University’s Staller Center for the Arts, 100 Nicolls Road, Stony Brook in the 1,000-seat Main Stage theater. Festival passes are on sale for $125, which guarantees entry to all live films at the Staller Center in July. Virtual passes are $85 with guaranteed access to all virtual films. For $250 you can purchase a Gold Pass, which guarantees entry and preferred seating for all live films at the Staller Center in July and full access to the Virtual Festival. Student passes are also available. For more information or to order, call the Staller Center Box Office at 631-632-2787 or visit stonybrookfilmfestival.com.

*This article first appeared in TBR News Media’s Summer Times supplement on June 24, 2021.

Pixabay photo

By Daniel Dunaief

Rain can put a damper on life, as the two children at the beginning of Dr. Seuss’s The Cat in the Hat shared and as the itsy bitsy spider that went up the water spout only to get washed out again discovered.

As it turns out, rain, clouds, wind and foul weather can reduce the trading decisions of people who buy and sell large sums of money in stocks, as they grapple with their own reactions to clouds that they’d like to go away and come again some other day.

Danling Jiang

Danling Jiang, associate dean of research and faculty development in Stony Brook University’s College of Business; Lin Sun, Assistant Professor at George Mason University; and Dylan Norris, Assistant Professor at Troy University recently published a study in which they explored the effect of cloudy or inclement weather in the two weeks before an earnings surprise on investor reactions.

Every three months, public companies provide a detailed disclosure of their profits and losses, giving investors a chance to look over the equivalent of a quarterly report card.

Like helicopter parents who monitor every line, sentence and word in a report card, institutional investors tend to have a stronger reaction, either positively or negatively, if those numbers are considerably different than they expected. An “A” in advanced calculus might be like profits that exceed estimates by 10 percent, while a “C” might be the equivalent of an unexpected loss in a business that had been doing well.

As it turns out, institutional investors are less likely to react as strongly, at least initially, to an earnings surprise if the skies in the two weeks before they review the earnings announcements are cloudy or unpleasant.

“We find strong supporting evidence in our empirical tests which reveal increases in the pre-announcement unpleasant weather of institutional investors results in muted immediate market responses to earnings news and amplified port-earnings-announcement drifts,” Jiang explained in an email.

Over the course of two to three months, the stock price reflects a more typical pattern that aligns with the direction of the earnings surprise.

The researchers published their work in the Journal of Corporate Finance.

These results, which came from an analysis of reactions to earnings surprises from 1990 to 2016, validate and extend previous efforts to understand how weather affects investor decisions.

Earlier studies revealed the effects of weather on individuals’ psychological and physiological states, according to Jiang.

“These effects have also been shown to influence financial decisions and security prices, even through the actions of sophisticated market participants such as market makers and security analysts,” she said.

The three academics started working together when Lin and Jiang were faculty and Norris was a PhD student at Florida State University.

“We were fascinated by the idea present in prior research that weather seems a perfect exogenous shock to investor psychology and physiology,” said Jiang. “This exogenous feature allows us to draw some causality of psychology on market pricing in a new setting with institutional investors and earnings announcements.”

The researchers chose the years 1990 to 2016 because they had the data in their possession.

“We tried to ensure that our sample period was long enough to confirm the weather effect was a persistent force throughout time and not merely a phenomenon of a small segment in time,” said Jiang who added that solving the weather-related muted effect by adding brighter lights to a trading floor could backfire, as excessive bright lights can have negative effects.

“Overillumination can cause fatigue, stress and anxiety,” she explained. “It is also likely that most traders are subject to the weather at some point during the day” through arriving at work, leaving for lunch or glancing out the window. That means the weather still likely influences them even when they may be in a brightly-lit indoor setting.

The researchers used two measures of weather conditions. One integrated wind, cloud and rain, and the other used cloud cover only. Both measures produced similar findings.

Using earlier studies and their own research, it appears accounting for the combined effect of simultaneous weather parameters or focusing on cloud cover better captures any physiological or psychological effects as opposed to using wind or rain alone, said Jiang.

Public companies are unlikely to trigger a more muted response to earnings surprises by recruiting investors from areas with greater cloud cover, as prior research demonstrated that seasonal climate norms don’t appear to affect the behavior of investors once they acclimate, so to speak, to the weather.

In addition to the 14-day window to create the weather measures, the researchers generated a seven-day measure that showed similar results.

Announcement day weather may also affect market reactions to earnings news and “we do not discredit its importance,” Jiang said. Indeed, other research has shown that the weather in New York City at the time of an earnings announcement impacts market reactions.

The explanation for the muted reaction to earnings is based on psychological and physiological reactions of institutional investors to weather, including anxiety and sadness as well as fatigue and decreased activity.

“In addition to causing delayed information processing, weather could cause a reduction in energy amongst some traders,” said Jiang

That means institutional investors may struggle with the same factors that made the boy and Sally from The Cat in the Hat struggle while it was “too wet to go out and too cold to play ball. So we sat in the house, we did nothing at all,” Dr. Seuss wrote.

While institutional investors don’t do nothing at all, they are less active, at least according to the recent research, than they are when the sun shines brightly, reliably and more consistently.

Photo courtesy of Getty Images

An electroencephalogram (EEG) study of adolescents with autism spectrum disorder (ASD) identified a neural signal that may help explain the variation of how those with ASD perceive or understand the mental states of others (called “Theory of Mind”). Led by Matthew Lerner, PhD, of Stony Brook University, the study is published in Clinical Psychological Science.

While challenges with Theory of Mind have long been associated with ASD, it is now known that many people with ASD do not struggle with his sort of perspective-taking. For example, those with increased autism symptoms do not necessarily exhibit increased deficits in the understanding others socially, and vice versa. However, this variability in Theory of Mind is not well understood.

A total of 78 adolescents ages 11 to 17 participated in the study, most with ASD. With the EEG in place, the participants viewed Theory of Mind vignettes of social scenes and made mental state inferences on the characters’ behavior as their brain activity was recorded.

“We know the brains of those with ASD process social experiences differently, yet little work has linked these differences directly to Theory of Mind,” says Lerner, Associate Professor of Psychology, Psychiatry & Pediatrics in the Department of Psychology at Stony Brook. “In our study, we first identified an electrical brain-based marker that relates to Theory of Mind ability in typically-developing teens, and found that it does so in ASD, too. This marker, called the Late Positive Complex (LPC), seems to reflect one’s ability to hold and reflect an idea or situation in one’s mind.”

Lerner and his team found that LPC scores in ASD adolescents related to better Theory of Mind accuracy and fewer ASD symptoms. More importantly, The LPC statistically explained the relationship between ASD symptoms and Theory of Mind accuracy, suggesting that this EEG signal may explain why some individuals with ASD struggle with Theory of Mind.

“Essentially, if this marker is present in someone with ASD, they do not seem to have trouble with Theory of Mind, but if it is absent they do.”

The authors point out that evidence from the EEG study suggests that deficits in Theory of Mind reasoning in those with ASD occur relatively early in the brain process of perception, and stem from difficulties holding an idea or image in mind when it is no longer visible.

They conclude that “the current findings increase understanding of the neural mechanisms implicated in social-cognitive functioning in ASD and further inform clinical practice, research and theory involving social cognition in ASD.”

 

Above, microscopic image showing brown, antibody-based staining of keratin 17 (K17) in bladder cancer. Image from Shroyer Lab, Stony Brook University

By Daniel Dunaief

Detectives often look for the smallest clue that links a culprit to a crime. A fingerprint on the frame of a stolen Picasso painting, a shoe print from a outside a window of a house that was robbed or a blood sample can provide the kind of forensic evidence that helps police and, eventually, district attorneys track and convict criminals.

Kenneth Shroyer MD, PhD                  Photo from SBU

The same process holds true in the world of disease detection. Researchers hope to use small and, ideally, noninvasive clues that will provide a diagnosis, enabling scientists and doctors to link symptoms to the molecular markers of a disease and, ultimately, to an effective remedy for these culprits that rob families of precious time with their relatives.

For years, Ken Shroyer, the Marvin Kuschner Professor and Chair of Pathology at the Renaissance School of Medicine at Stony Brook University, has been working with a protein called keratin 17.

A part of embryological development, keratin 17 was, at first, like a witness who appeared at the scene of one crime after another. The presence of this specific protein, which is unusual in adults, appeared to be something of a fluke.

Until it wasn’t.

Shroyer and a former member of his lab, Luisa Escobar-Hoyos, who is now an Assistant Professor at Yale, recently published two papers that build on their previous work with this protein. One paper, which was published in Cancer Cytopathology, links the protein to pancreatic cancer. The other, published in the American Journal of Clinical Pathology, provides a potentially easier way to diagnose bladder cancer, or urothelial carcinoma.

Each paper suggests that, like an abundance of suspicious fingerprints at the crime scene, the presence of keratin 17 can, and likely does, have diagnostic relevance.

Pancreatic cancer

A particularly nettlesome disease, pancreatic cancer, which researchers at Stony Brook and Cold Spring Harbor Laboratory, including CSHL Cancer Center Director David Tuveson, have been studying for years, has a poor prognosis upon diagnosis.

During a process called surgical resection, doctors have been able to determine the virulence of pancreatic cancer by looking at a larger number of cells.

Shroyer and Escobar Hoyos, however, used a needle biopsy, in which they took considerably fewer cells, to see whether they could develop a k17 score that would correlate with the most aggressive subtype of the cancer.

“We took cases that had been evaluated by needle biopsy and then had a subsequent surgical resection to compare the two results,” Shroyer said. They were able to show that the “needle biopsy specimens gave results that were as useful as working with the whole tumor in predicting the survival of the patient.”

A needle biopsy, with a k17 score that reflects the virulence of cancer, could be especially helpful with those cancers for which a patient is not a candidate for a surgical resection.“That makes this type of analysis available to any patient with a diagnosis of pancreatic cancer, rather than limiting it to the small subset of cases that are able to undergo surgery,” Shroyer said. 

Ultimately, however, a k17 score is not the goal for the chairman of the pathology department.

Indeed, Shroyer would like to use that score as a biomarker that could differentiate patient subtypes, enabling doctors to determine a therapy that would prove most reliable for different groups of people battling pancreatic cancer.

The recently published report establishes the foundation of whether it’s possible to detect and get meaningful conclusions from a needle biopsy in terms of treatment options.

At this point, Shroyer isn’t sure whether these results increase the potential clinical benefit of a needle biopsy.

“Although this paper supports that hypothesis, we are not prepared yet to use k17 to guide clinical decision making,” Shroyer said.

Bladder cancer

Each year, doctors and hospitals diagnose about 81,000 cases of bladder cancer in the United States. The detection of this cancer can be difficult and expensive and often includes an invasive procedure.

Shroyer, however, developed a k17 protein test that is designed to provide a reliable diagnostic marker that labs can get from a urine sample, which is often part of an annual physical exam.

The problem with bladder cancer cytopathology is that the sensitivity and specificity aren’t high enough. Cells sometimes appear suggestive or indeterminate when the patient doesn’t have cancer.

“There has been interest in finding biomarkers to improve diagnostic accuracy,” Shroyer said. 

Shroyer applied for patent protection for a k17 assay he developed through the Stony Brook Technology Transfer office and is working with KDx Diagnostics. The work builds on “previous observations that k17 detects bladder cancer in biopsies,” Shroyer said. He reported a “high level of sensitivity and specificity” that went beyond that with other biomarkers.

Indeed, in urine tests of 36 cases confirmed by biopsy, 35 showed elevated levels of the protein.

KDx, a start up biotechnology company that has a license with The Research Foundation for The State University of New York, is developing the test commercially.

The Food and Drug Administration gave KDx a breakthrough device designation for its assay test for k17.

Additionally, such a test could reveal whether bladder cancer that appears to be in remission may have recurred.

This type of test could help doctors with the initial diagnosis and with follow up efforts, Shroyer said.“Do patients have bladder cancer, yes or no?” he asked. “The tools are not entirely accurate. We want to be able to give a more accurate answer to that pretty simple question.”

From left, Eleanor Lalima and Lisa Figueroa Filosa. Photo from Stony Brook Medicine

Two best friends on Long Island are now sharing a bond like no other, a set of kidneys.

Eleanor Lalima of Ronkonkoma and Lisa Figueroa Filosa of Deer Park have been best friends since they met in the 1st grade. Through getting married and having children of their own, the duo have stayed close throughout their more than 30 year friendship, so it wasn’t a surprise to anyone they knew when Lisa answered the call to help out when her friend needed her most.

Eleanor has been battling kidney disease since age 16. Not only did she face the disease, but she lost both her mother and her brother to kidney disease. While a patient at Stony Brook University Hospital (SBUH), Eleanor learned her next treatment option was receiving a kidney transplant. 

Soon after, Eleanor put out a call for help on Facebook. Several of Eleanor’s family and friends reached out right away to get tested including her lifelong best friend Lisa. Lisa was actually the first to get tested and called Eleanor to tell her she had a good match for a transplant.

“My mother was on the transplant list for over 8 years due to her rare blood type and she didn’t get the same chance I have now,” says Eleanor. “To get a kidney in such a short time is really amazing and it gives me a chance at a better life.”

Dr. Wayne Waltzer, Professor and Chairman of the Department of Urology and Director of Kidney Transplantation Program at Stony Brook University Hospital, and Dr. Frank Darras, Clinical/Medical Director of the Renal Transplantation Program at Stony Brook University Hospital, who cared for other members of her family, played a large role in Eleanor’s treatment at Stony Brook.

“Kidney disease can take a toll on an entire family. Being a transplant surgeon and being able to assist in restoring one’s quality of life is truly a rewarding experience,” said Dr. Darras. “But the true hero here is Lisa. Without her none of this would have been possible!”

On May 25, spirits were high as Eleanor and Lisa went in for surgery at SBUH. The surgery was a success and the friends were discharged within a week.

“Just when you think a lifelong friendship can’t be any stronger, you share a kidney,” said Lisa.

Kidney disease affects an estimated 37 million people in the U.S. (15% of the adult population; more than 1 in 7 adults). It is the leading cause of death in the U.S. according to the National Kidney Foundation, causing more deaths than breast cancer or prostate cancer.

For more information about Kidney Transplantation Services at Stony Brook Medicine, visit stonybrookmedicine.edu/patientcare/transplant.

Eric Rashba, MD, Director, Heart Rhythm Center; Puja Parikh, MD; Interventional Cardiologist; and Smadar Kort, MD, Director of Non-Invasive Cardiac Imaging, in Stony Brook’s Advanced Multifunctional Cath/EP Lab. Photo by Jim Lennon/ SB Medicine

Stony Brook University Heart Institute is now offering its patients the latest generation of the Watchman FLX™ device, which provides protection from strokes for people who have atrial fibrillation (AFib), a type of arrhythmia or irregular heartbeat, that is not caused by a heart valve problem.

Eric Rashba, MD, Director, Heart Rhythm Center holding the new Watchman FLX device. Photo by Jim Lennon/SB Medicine

Stony Brook is one of a select number of sites in New York State to offer the new Watchman FLX device. The procedure, which closes off the part of the heart where 90% of stroke-causing clots come from, will be done in Stony Brook University Hospital’s new Advanced Multifunctional Cath/EP Lab. The large, 845-square-foot multi-functional laboratory has been carefully designed and outfitted with state-of-the-art technology to allow the Heart Institute physicians to perform a full range of procedures.

People with AFib, the most common type of heart rhythm disorder, have an increased risk of stroke by 5 times on average. Blood thinners are often prescribed to help prevent strokes but “some experience bleeding problems or have other reasons why blood thinners aren’t the best option,” explains Eric Rashba, MD, Director, Heart Rhythm Center at Stony Brook Heart Institute.

The Watchman device, which is about the size of a quarter, provides an alternative to the lifelong use of blood thinners (anticoagulants) for people with AFib by blocking blood clots from leaving the heart and possibly causing a stroke.

The design of the newer, Watchman FLX device used by the Heart Institute offers significant advantages to the patient, including:

  • Advanced safety due to the new framing of the device that allows for more long-term stability and a more complete seal

  • Enhanced procedural performance that allows the physician to better maneuver and position the device during the procedure

  • A broader size range to permit treatment of a wider range of patient anatomies

“At the Stony Brook Heart Rhythm Center, in the hands of our expert team, we are excited to bring this latest innovation to effectively provide protection equivalent to anticoagulants for preventing strokes and avoiding the risk of serious bleeding,” said Dr. Rashba. “It has saved lives and improved my patients’ quality of life.”

Wai Law. Photo from Stony Brook Medicine
Wai Law, 54, of Bethpage will be running 555 miles starting June 25 on the newly completed Empire State Trail from Buffalo to Battery Park, NYC in order to raise funds for The Thomas Hartman Center for Parkinson’s Research at Stony Brook University. Last year, he raised more than $10,000 and completed 103 miles from New Paltz to Citi Field Queens in 24 hours.
His goal this year is to complete 555 miles in about 10 days unassisted while pushing a baby/pet jogging stroller stocked with supplies and light camping gear. 
Wai explains, “For me, outdoor activities, running in particular, are more than just forms of exercise. It is also a powerful way to help various organizations, communities, and families. I run for those who can’t, I run to raise funds for important medical research, and I run to help pay for expenses that a family may need while dealing with a medical crisis.” 
These runs have tremendous meaning to continue the efforts to increase awareness of Parkinson’s, raise money for research and honor the memory of Ruben Almodovar, the father of Wai’s longtime friend of 15 years, Dennis Almodovar, 53, of Massapequa. Ruben Almodovar battled Parkinson’s for 12 years, from 2005 to 2017, and passed at 80 years old.  
Dennis and Wai bonded 15 years ago at a charity event and have since entered and completed many long runs or marathons. 
“We are very grateful to Wai and Dennis for leading this extraordinary initiative in support of The Thomas Hartman Center for Parkinson’s Research at Stony Brook University,” said Dr. Alfredo Fontanini, chair of the Department of Neurobiology & Behavior at Stony Brook University. “Their friendship, support and ability to raise awareness for Parkinson’s disease are truly inspiring. This year’s event is absolutely incredible, running 555 miles, in 10 days, unassisted is an exceptional feat and we will be rooting for Wai.”
To get ready for the big run on June 25, this coming Saturday, June 12 at Sunken Meadow State Park in Kings Park, friends and other supporters from Stony Brook will meet in Parking Lot 1 and gather from 7am to 10am to run along the boardwalk and throughout the park. For those wishing to donate to the center’s Parkinson’s research, here’s the form

The Hartman Center was established in 2013 within the Department of Neurobiology and Behavior at Stony Brook University through a generous gift from the Thomas Hartman Foundation for Parkinson Research that was matched by the Simons Foundation, according to Fontanini. Every year, the Center awards grants to support innovative research projects at Stony Brook University. The goal is to advance our understanding of Parkinson’s disease and help the development of new therapeutic approaches.

“The support from the Hartman Center has helped jump starting a series of very innovative research projects. It brought new researchers into the field and sparked new collaborations between scientists at Stony Brook University,” Fontanini said. “The projects supported by the Center are typically multidisciplinary. They rely on new technologies and methods to open new alleys of research or address under-studied problems in the field. Over the years, the Center funded work aimed at understanding the genetic and molecular causes of Parkinson’s disease or the neurobiological bases of motor and non-motor symptoms.”

Wai also added a second charity to raise money for: Leukemia & Lymphoma Society and established “Wai’s 50 Yard Stroller Challenge” to encourage the public’s active involvement. To participate, members of the public are encouraged to find a stroller, cart, wheel barrel, or something else to push. Add some weight to it and run 50 yards for The Thomas Hartman Center for Parkinson’s Research at Stony Brook University and the Leukemia Lymphoma Society. Donate $5 (or more) to one or both charities. When you complete the challenge, post it on your social page (Facebook, Twitter, Instagram), tag @empirestatetrailb2brun and use #strollerchallenge, and challenge 5 friends.
To follow Wai Law’s journey on Facebook, visit: https://www.facebook.com/EmpireStateTrailB2BRun.

File photo

Analysis of surface water samples performed by SUNY Stony Brook has confirmed the presence of new cyanobacteria blooms, more commonly known as blue–green algae, in in Old Town Pond in Southampton, Mill Pond in Water Mill, Artist Lake in Middle Island, New Mill Pond (also known as Blydenburgh Lake) in Smithtown.

Due to these findings, health officials ask residents not to use or swim or wade in these waters and to keep their children and pets away from the area.

Though blue-green algae are naturally present in lakes and streams in low numbers, they can become abundant, forming blooms in shades of green, blue-green, yellow, brown or red. They may produce floating scums on the surface of the water or may cause the water to take on paint-like appearance.

Contact with waters that appear scummy or discolored should be avoided. If contact does occur, rinse off with clean water immediately.  Seek medical attention if any of the following symptoms occur after contact: nausea, vomiting or diarrhea; skin, eye or throat irritation, allergic reactions or breathing difficulties.

To view a map all affected fresh waterbodies in New York State, or to report a suspected blue-green algae bloom to the New York State Department of Environmental Conservation (NYSDEC) at a body of water that does not contain a Suffolk County permitted bathing beach please use:  NYHABS.

Any questions should be emailed to [email protected].

To report a suspected blue-green algae bloom at a body of water that does contain a Suffolk County-permitted bathing beach, contact the Suffolk County Department of Health Services’ Office of Ecology at 631-852-5760 between 8:30 a.m. and 4:30 p.m. or by email at any time at [email protected]

For additional information about blue-green algae, as well as other harmful algal blooms, visit the following websites:

https://www.suffolkcountyny.gov/Departments/Health-Services/Environmental-Quality/Ecology/Harmful-Algal-Blooms

https://www.health.ny.gov/environmental/water/drinking/bluegreenalgae/

https://www.dec.ny.gov/chemical/77118.html

Pixabay photo

The COVID-19 Pandemic shifted the workforce, especially here in New York as it was in the epicenter of the outbreak. Whether laid off, furloughed, or having to leave a job in order to attend to family needs like homeschooling or aging parents, things are beginning to shift back to a more normal way of life.

Marie Parziale

Now, as people are looking to get back into the workforce, Stony Brook University is here to help. The Stony Brook University Career Center is hosting a two-day virtual workshop series, hosted by Senior Career Coach Marie Parziale, which is open to the public. This workshop is designed to aid recent graduates and displaced workers in need of support and resources to help with the job search.

Sessions are as follows:

Session One: Thursday, June 24, 2021 from 7 pm to 8 pm
Resume/Cover Letter Review and the Value of Assessments
In session one, Marie Parziale, Sr. Career Coach will share tips and resources with community members on creating and improving their resumes and cover letters for job applications.  She will also discuss the value of assessments and how they can help prepare you for your job search.

Session Two: Friday, June 25, 2021 from 1 pm to 2 pm
Managing Your Job Search
In session two, participants will learn how to brand themselves throughout the job search and how to build and maintain a LinkedIn profile. Tips will also be shared on how to network using LinkedIn to stand out while looking for your next opportunity.

Both sessions are virtual. Register here.